Metabolic STAMP for deciphering GPCR-regulated insulin secretion by pancreatic β cells

  • bioRxiv. 2025 Oct 4:2025.10.03.680349. doi: 10.1101/2025.10.03.680349.
Mohammad Ovais Aziz-Zanjani  1  2 Rachel E Turn  1  2 Yan Hang  3  2 Anushweta Asthana  1 Leilani Elizabeth LaBrie  1 Mohammadamin Mobedi  1 Lucy Artemis Xu  1 Michael Krawitzky  4 Seung K Kim  3  2 Peter K Jackson  1  2
Affiliations
  • 1. Baxter Laboratory, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • 2. Co-corresponding authors.
  • 3. Stanford Diabetes Research Center, Department of Developmental Biology, Stanford University School of Medicine, Stanford CA 94305, USA.
  • 4. Bruker Scientific, San Jose, CA, USA.
Abstract

Pancreatic β cells integrate glucose and metabolic cues to regulate Insulin secretion, a process disrupted in T2D. GPCRs play a critical role in fine-tuning Insulin release, yet the mechanisms by which ciliary (e.g., FFAR4) and non-ciliary (e.g., GLP1-R) GPCRs coordinate GSIS remains unclear. In this study, we employed Metabolic-STAMP (Synchronized Temporal-Spatial Analysis via Microscopy and Phosphoproteomics) in both mouse β cells (MIN6) and primary human islets to map the dynamic signaling networks governing GSIS and to link transient phosphorylation events to their functional outcomes. We systematically interrogated GPCR-mediated phosphorylation events through selective pharmacological inhibitors, resolving signaling hierarchies and consensus patterns across multiple pathways. Our multi-modal approach uncovered key insulin-secretion-associated PTMs, linked phosphorylation targets with phenotypic organelle dynamics, and provided mechanistic insights into how GLP1-R versus FFAR4 modulates GSIS through shared and GPCR-specific phospho-signatures. We highlighted key examples of stimulus-specific regulation by high glucose alone versus GPCR stimulation, including context-specific activation of the classic ERK signaling pathway, compartmentalized PKA signaling, pathway specificity in organelle dynamics and inter-organellar contacts, and HDAC6/ATAT-mediated regulation of microtubule acetylation. Collectively, these findings provided a blueprint for deconvolving pathway specificity of β cell GPCR signaling, illuminated regulatory nodes that program Insulin release, and offered new therapeutic targets to enhance β-cell function.

Keywords
ATAT1; ERK; FFAR4 (Free Fatty Acid Receptor 4); GLP1-R (Glucagon-Like Peptide-1 Receptor); GPCRs (G protein-coupled receptors); GSIS (glucose-stimulated insulin secretion); HDAC6 (Histone De-Acetylase 6); MIN6 (mouse β-cell line); Metabolic-STAMP (Synchronized Temporal-Spatial Analysis via Microscopy and Phosphoproteomics); PKA (Protein Kinase A); PTMs (post-translational modifications); T2D (Type 2 Diabetes); acetylation; inter-organellar contacts; microtubules; primary human islets.
Products